Skip to content

Randomised trial, 1996

Is sertraline better than desipramine for treating premenstrual syndrome?

Both medications reduced depressive symptoms. Sertraline appeared to work better overall and was much better tolerated. However, the study was not properly blinded and the sample was very small, so we cannot be certain.

Early or limited evidence 17 women on sertraline and 15 on desipramine with PMS

What they did

Open-label (not blinded) comparison for 2 menstrual cycles. 17 women took sertraline and 15 took desipramine. Doses were flexible, averaging 87 mg/day for sertraline and 110 mg/day for desipramine.

What they found

Both medications reduced depressive symptoms similarly. Sertraline showed greater reduction in total premenstrual symptoms but the difference was not statistically significant in this small sample. Desipramine side effects were intolerable for more women: 4 of 15 discontinued, compared to none in the sertraline group.

What it means for you

Sertraline was better tolerated, but because the study was not blinded and very small, the researchers say a proper placebo-controlled trial is needed to confirm the findings.

17

women on sertraline

4 of 15

desipramine users stopped treatment

87 mg/day

mean sertraline dose

About the study

Original title
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial
Authors
Freeman EW, Rickels K, Sondheimer SJ et al.
Journal
The Journal of clinical psychiatry
Year
1996
Study design
Randomised trial
Participants
17
What was tested
Sertraline (mean 87 mg/day) or desipramine (mean 110 mg/day) for 2 menstrual cycles

Topics